• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to Interleukin (IL)-17 Inhibition in an Adolescent With Severe Manifestations of IL-36 Receptor Antagonist Deficiency (DITRA).

作者信息

Cordoro Kelly M, Ucmak Derya, Hitraya-Low Maria, Rosenblum Michael D, Liao Wilson

机构信息

Department of Dermatology, University of California-San Francisco School of Medicine, San Francisco.

出版信息

JAMA Dermatol. 2017 Jan 1;153(1):106-108. doi: 10.1001/jamadermatol.2016.3490.

DOI:10.1001/jamadermatol.2016.3490
PMID:27760239
Abstract
摘要

相似文献

1
Response to Interleukin (IL)-17 Inhibition in an Adolescent With Severe Manifestations of IL-36 Receptor Antagonist Deficiency (DITRA).一名患有白细胞介素36受体拮抗剂缺乏症（DITRA）严重表现的青少年对白细胞介素（IL）-17抑制的反应
JAMA Dermatol. 2017 Jan 1;153(1):106-108. doi: 10.1001/jamadermatol.2016.3490.
2
Secukinumab for the Treatment of Deficiency of Interleukin 36 Receptor Antagonist in an Adolescent.司库奇尤单抗治疗青少年白细胞介素36受体拮抗剂缺乏症
JAMA Dermatol. 2017 May 1;153(5):473-475. doi: 10.1001/jamadermatol.2016.5705.
3
Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA.Toll 样受体 4 拮抗剂 TAK-242 抑制 DITRA 的自身炎症症状。
J Autoimmun. 2017 Jun;80:28-38. doi: 10.1016/j.jaut.2017.01.007. Epub 2017 Feb 11.
4
Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work.成功使用司库奇尤单抗单药治疗难治性青少年泛发性脓疱型银屑病：一例病例报告及文献复习。
J Dermatol. 2018 Nov;45(11):1353-1356. doi: 10.1111/1346-8138.14636. Epub 2018 Sep 19.
5
Cutaneous findings and treatments in deficiency of interleukin-36 receptor antagonist (DITRA): A review of the literature.白细胞介素-36 受体拮抗剂（DITRA）缺乏症的皮肤表现和治疗：文献复习。
Exp Dermatol. 2024 Jan;33(1):e14934. doi: 10.1111/exd.14934. Epub 2023 Sep 19.
6
Successful treatment with interleukin-17A antagonists of generalized pustular psoriasis in patients without IL36RN mutations.白细胞介素-17A 拮抗剂治疗无 IL36RN 突变的泛发性脓疱型银屑病患者获得成功。
J Dermatol. 2018 Jul;45(7):850-854. doi: 10.1111/1346-8138.14318. Epub 2018 Apr 14.
7
Deficiency of the interleukin-36 receptor antagonist dramatically improved by secukinumab.
J Dermatol. 2018 Oct;45(10):e280-e281. doi: 10.1111/1346-8138.14330. Epub 2018 Apr 17.
8
Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis.古塞单抗（一种针对 IL-23 的 mAb）可使中重度斑块状银屑病患者获得临床和分子应答。
J Allergy Clin Immunol. 2014 Apr;133(4):1032-40. doi: 10.1016/j.jaci.2014.01.025.
9
Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents.儿童和青少年白细胞介素-36 受体拮抗剂缺乏症（DITRA）的生物治疗的范围综述。
Pediatr Rheumatol Online J. 2019 Jul 8;17(1):37. doi: 10.1186/s12969-019-0338-1.
10
IL36RN mutation causing generalized pustular psoriasis in a Palestinian patient.IL36RN基因突变导致一名巴勒斯坦患者患泛发性脓疱型银屑病。
Int J Dermatol. 2014 Jul;53(7):866-8. doi: 10.1111/ijd.12525. Epub 2014 Jun 5.

引用本文的文献

1
Updates in the Management of Hereditary Periodic Fever Syndromes in Children.儿童遗传性周期性发热综合征的管理进展
Cureus. 2025 Apr 15;17(4):e82284. doi: 10.7759/cureus.82284. eCollection 2025 Apr.
2
The Role of IL-17 in Systemic Autoinflammatory Diseases: Mechanisms and Therapeutic Perspectives.白细胞介素-17在全身自身炎症性疾病中的作用：机制与治疗前景
Clin Rev Allergy Immunol. 2025 Mar 12;68(1):27. doi: 10.1007/s12016-025-09042-5.
3
Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search.
泛发性脓疱型银屑病的当前治疗方法：系统文献检索的叙述性总结
Dermatol Ther (Heidelb). 2024 Sep;14(9):2331-2378. doi: 10.1007/s13555-024-01230-z. Epub 2024 Aug 1.
4
IL-1 Family Antagonists in Mouse and Human Skin Inflammation.IL-1 家族拮抗剂在鼠和人皮肤炎症中的作用。
Front Immunol. 2021 Mar 16;12:652846. doi: 10.3389/fimmu.2021.652846. eCollection 2021.
5
Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis-A Review.儿童银屑病和特应性皮炎的生物治疗选择——综述
J Clin Aesthet Dermatol. 2020 Jun;13(6 Suppl):S33-S38. Epub 2020 Jun 1.
6
Autoinflammatory Keratinization Diseases (AiKDs): Expansion of Disorders to Be Included.自身炎症性角化病（AiKDs）：纳入疾病范围的扩展
Front Immunol. 2020 Feb 21;11:280. doi: 10.3389/fimmu.2020.00280. eCollection 2020.
7
Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis.儿童银屑病和特应性皮炎的生物治疗选择
Children (Basel). 2019 Sep 11;6(9):103. doi: 10.3390/children6090103.
8
Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents.儿童和青少年白细胞介素-36 受体拮抗剂缺乏症（DITRA）的生物治疗的范围综述。
Pediatr Rheumatol Online J. 2019 Jul 8;17(1):37. doi: 10.1186/s12969-019-0338-1.
9
Mechanisms of Inflammation in Neutrophil-Mediated Skin Diseases.中性粒细胞介导的皮肤疾病中的炎症机制。
Front Immunol. 2019 May 8;10:1059. doi: 10.3389/fimmu.2019.01059. eCollection 2019.
10
Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA.关于在弥漫性特发性骨肥厚（DIRA）和弥漫性掌跖角化病伴脓疱病（DITRA）中使用靶向白细胞介素1通路药物的范围综述。
Dermatol Ther (Heidelb). 2018 Dec;8(4):539-556. doi: 10.1007/s13555-018-0269-7. Epub 2018 Nov 3.